{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Sydnexis: Pearls from a pediatric ophthalmologist entrepreneur a decade in","description":"Gregory Ostrow, MD, joins Jennifer Galvin, MD, to discuss his entrepreneurism in pediatric ophthalmology and the starting of Sydnexis, a clinical-stage biopharmaceutical company he founded. He describes the journey to discovering a way to neutralize and stabilize compounded atropine eye drops to effectively treat myopia in pediatric patients. He also shares information from the STAR study, a phase 3 clinical trial evaluating the company\u2019s patented formulation of low-dose atropine for myopia control. ","author_name":"Little Eyes, Big Topics","author_url":"https:\/\/littleeyesbigtopics.libsyn.com","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/36481770\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/item\/36481770"}